Lifenol Hops Extract
Also known as: Lifenol, 8-prenylnaringenin, Humulus lupulus extract, Lifenol™ (Hops Extract)
Overview
Lifenol™ is a patented extract derived from the female flowers of the hops plant (*Humulus lupulus*), designed to be rich in 8-prenylnaringenin (8-PN), a well-known phytoestrogen. This extract, traditionally used in brewing and as a herbal remedy, is becoming increasingly recognized for its benefits in managing menopausal symptoms, such as hot flashes and sleep disturbances, and is also noted for its role in supporting bone health. Sourced sustainably from Germany, Lifenol™ is a 100% natural product that has been the subject of robust research, including randomized, double-blind, placebo-controlled clinical trials that validate its efficacy and safety. The supplement has received approval for health claims in various countries, positioning Lifenol™ as a notable option within the supplement market for women experiencing menopause.
Benefits
The primary benefits of Lifenol™ are evident for postmenopausal women, evidenced by clinical trials that reveal a significant reduction in menopausal symptoms with a daily intake of 85 mg within six weeks. A 2023 study highlighted a 1.8% increase in total bone mineral density over 48 weeks when Lifenol™ is taken in conjunction with vitamin D3 and calcium. Additional benefits include improvements in physical quality of life and functional health, facilitating greater engagement in physical activities. Some research suggests potential synergistic effects with other phytoestrogens that could enhance the overall menopausal health outcomes.
How it works
The efficacy of Lifenol™ stems from its active ingredient, 8-prenylnaringenin, which acts as a phytoestrogen by binding to estrogen receptors within the body. This mechanism helps to modulate various physiological processes associated with menopause, aiding in relief from symptoms and the preservation of bone density. The unique prenylated structure of this hop-derived phytochemical enhances its absorption and metabolism, allowing for effective interactions with the endocrine systems crucial for managing menopausal symptoms and supporting bone health.
Side effects
Lifenol™ is typically well tolerated, and clinical studies have not reported any significant adverse effects at the daily recommended dosage of 85 mg. The incidence of common side effects is infrequent, noted at less than 5%. The literature does not detail any uncommon or rare side effects. However, minor drug interactions may occur primarily related to the CYP3A4/5 enzyme pathways. While there are no specific contraindications, individuals with estrogen-sensitive conditions should exercise caution. It is advisable for individuals with underlying health issues, notably postmenopausal women, to consult healthcare professionals for supervision during use.
Dosage
The recommended dosage of Lifenol™ is 85 mg per day, ingested in a single dose. Although there are no established upper limits, this dosage has consistently shown significant health benefits with a minimal side effect profile. The timing of Lifenol™ intake is flexible, but regular consumption is crucial to maintaining therapeutic levels. It is recommended to take Lifenol™ alongside a standard vitamin D3 and calcium to enhance its effects on bone health. Available as a standardized extract, Lifenol™ is formulated to optimize absorption and bioavailability.
FAQs
Is Lifenol™ safe for everyone?
While generally considered safe, individuals with estrogen-sensitive conditions should consult healthcare providers before use.
When should I take Lifenol™?
It can be taken at any time of day, but taking it consistently is recommended for best results.
How long until I see results?
Improvements in menopausal symptoms are typically noticeable within 6 weeks, with bone health benefits emerging over 48 weeks.
Is Lifenol™ a hormone therapy?
No, Lifenol™ is a phytoestrogenic supplement, not a hormone replacement therapy.
Research Sources
- https://example.com/lifenol-study-2023 – A 2023 clinical trial highlighted the effectiveness of Lifenol™ in improving total bone mineral density by 1.8% over a 48-week period when accompanied by vitamin D3 and calcium. The randomized, double-blind, placebo-controlled design strengthens the study's findings, offering strong evidence for the supplement’s efficacy.
- https://example.com/lifenol-efficacy – Numerous studies substantiate the efficacy of Lifenol™ in reducing menopausal symptoms in postmenopausal women, demonstrating significant improvements in quality of life. The meta-analysis incorporates data from various clinical trials, establishing a basis for health claims associated with the product.
